Promising single-dose malaria treatment advances toward pan-African clinical trial

Medical Xpress

Promising single-dose malaria treatment advances toward pan-African clinical trial

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for patients.

The four-drug combination treatment, known as SPAP, is now being prepared for large-scale clinical testing across Africa.

Prof.

Ghyslain Mombo-Ngoma, who was named to the 2026 TIME100 Health list in recognition of his contributions to global health research, is co-leading the project. ...

전문 보기

Promising single-dose malaria treatment advances toward pan-African clinical trial

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Steep drop in metabolic coenzyme could trigger preterm labor

A partner's touch can feel unsafe for people with a history of childhood maltreatment

Physical exercise could help modulate the immune response in type 1 diabetes

Medical Xpress의 다른 기사

Fat tissue could explain triple negative breast cancer spread—and point to treatments

Tracking the flow of cerebrospinal fluid reveals an unprecedented view of the brain's glymphatic system

Scientists discover a biological 'pencil' that improves health through nutrition